Cargando…

Reversal of multidrug resistance by 5,5’-dimethoxylariciresinol-4-O-β-D-glucoside in doxorubicin-resistant human leukemia K562/DOX

OBJECTIVE: The objective of this study was to investigate the reversal effects of 5,5’-dimethoxylariciresinol-4’-O-β-D-glucoside (DMAG) extracted from traditional Chinese medicines Mahonia on multidrug resistance (MDR) of human leukemia cells to chemotherapeutic agents. MATERIALS AND METHODS: MTT(3-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Tian-Xiao, Shi, Xiao-Yan, Cong, Yue, Wang, Shi-Guang, Wang, Ying-Ying, Zhang, Zhong-Qin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847250/ https://www.ncbi.nlm.nih.gov/pubmed/24347768 http://dx.doi.org/10.4103/0253-7613.121371

Ejemplares similares

Effect of CIK on multidrug-resistance reversal and increasing the sensitivity of ADR in K562/ADR cells
por: WANG, LEI, et al.
Publicado: (2014)

Role of the aclacinomycin A--doxorubicin association in reversal of doxorubicin resistance in K562 tumour cells.
por: Millot, J. M., et al.
Publicado: (1989)

Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin
por: Xue, Chaojun, et al.
Publicado: (2016)

Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells
por: HUANG, FANG, et al.
Publicado: (2014)

Curcumin increases the sensitivity of K562/DOX cells to doxorubicin by targeting S100 calcium-binding protein A8 and P-glycoprotein
por: Yang, Liu, et al.
Publicado: (2020)

Tuberostemonine reverses multidrug resistance in chronic myelogenous leukemia cells K562/ADR
por: Wang, Yu Jia, et al.
Publicado: (2017)

In Vitro Antileukemia Activity of ZSTK474 on K562 and Multidrug Resistant K562/A02 Cells
por: Zhou, Qianxiang, et al.
Publicado: (2016)

Trifluoperazine prevents FOXO1 nuclear excretion and reverses doxorubicin-resistance in the SHG44/DOX drug-resistant glioma cell line
por: Chen, Xiaozhong, et al.
Publicado: (2018)

Recombinant methioninase combined with doxorubicin (DOX) regresses a DOX-resistant synovial sarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model
por: Igarashi, Kentaro, et al.
Publicado: (2018)

Effect of magnetic nanoparticles of Fe(3)O(4) and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02 leukemic cells
por: Cheng, Jian, et al.
Publicado: (2009)

Screening Multidrug Resistance Reversal Agents in Traditional Chinese Medicines by Efflux Kinetics of D-Luciferin in MCF-7/DOX(Fluc) Cells
por: Zhao, Yue, et al.
Publicado: (2023)

A New Chalcone Derivative C49 Reverses Doxorubicin Resistance in MCF-7/DOX Cells by Inhibiting P-Glycoprotein Expression
por: Wang, Ting, et al.
Publicado: (2021)

Genomic amplification of chromosome 7 in the Doxorubicin resistant K562 cell line
por: Ibrahim, Sara.M, et al.
Publicado: (2018)

Knockdown of HOXA10 reverses the multidrug resistance of human chronic mylogenous leukemia K562/ADM cells by downregulating P-gp and MRP-1
por: Yi, Ying-Jie, et al.
Publicado: (2023)

Doxorubicin-Induced Autophagolysosome Formation Is Partly Prevented by Mitochondrial ROS Elimination in DOX-Resistant Breast Cancer Cells
por: Ahmadpour, Seyedeh Tayebeh, et al.
Publicado: (2021)

Nano‐gold micelles loaded Dox and Elacridar for reversing drug resistance of breast cancer
por: Wen, Liu‐Jing, et al.
Publicado: (2022)

Oxidative phosphorylation activation is an important characteristic of DOX resistance in hepatocellular carcinoma cells
por: Wu, Li, et al.
Publicado: (2018)

Dexrazoxane significantly impairs the induction of doxorubicin resistance in the human leukaemia line, K562
por: Sargent, J M, et al.
Publicado: (2001)

Modulation of p-glycoprotein-mediated efflux pirarubicin in living multidrug-resistant K562/Dox cell lines by 4-hydroxybenzoic acid and 4-hydroxy-3-methoxybenzoic acid via impairment of the cellular energetic state
por: Myint, Ohnmar, et al.
Publicado: (2022)

Inhibition of p38 MAPK diminishes doxorubicin-induced drug resistance associated with P-glycoprotein in human leukemia K562 cells
por: Chen, Yinghui, et al.
Publicado: (2012)

Pentagalloyl Glucose-Targeted Inhibition of P-Glycoprotein and Re-Sensitization of Multidrug-Resistant Leukemic Cells (K562/ADR) to Doxorubicin: In Silico and Functional Studies
por: Dechsupa, Nathupakorn, et al.
Publicado: (2023)

Fulvestrant reverses doxorubicin resistance in multidrug-resistant breast cell lines independent of estrogen receptor expression
por: Huang, Yuan, et al.
Publicado: (2017)

CTL–doxorubicin (DOX)–gold complex nanoparticles (DOX–AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model
por: Liu, Qiqian, et al.
Publicado: (2020)

Synthesis of 5-oxyquinoline derivatives for reversal of multidrug resistance
por: Dittrich, Torsten, et al.
Publicado: (2012)

DOX sensitized upconversion metal–organic frameworks for the pH responsive release and real-time detection of doxorubicin hydrochloride
por: Tian, Feng, et al.
Publicado: (2020)

Correction: CTL–doxorubicin (DOX)–gold complex nanoparticles (DOX–AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model
por: Liu, Qiqian, et al.
Publicado: (2022)

Effect of magnetic nanoparticles of Fe(3)O(4) and wogonin on the reversal of multidrug resistance in K562/A02 cell line
por: Cheng, Jian, et al.
Publicado: (2012)

Nanomicelles loaded with doxorubicin and curcumin for alleviating multidrug resistance in lung cancer
por: Gu, Yue, et al.
Publicado: (2016)

Reversal of ABCB1-related multidrug resistance by ERK5-IN-1
por: Wang, Fang, et al.
Publicado: (2020)

Phase I Study of Intravenous PSC‐833 and Doxorubicin: Reversal of Multidrug Resistance
por: Minami, Hironobu, et al.
Publicado: (2001)

A Versatile PDA(DOX) Nanoplatform for Chemo-Photothermal Synergistic Therapy against Breast Cancer and Attenuated Doxorubicin-Induced Cardiotoxicity
por: Geng, Siqi, et al.
Publicado: (2023)

Reversal of Multidrug Resistance by Apolipoprotein A1-Modified Doxorubicin Liposome for Breast Cancer Treatment
por: An, Duopeng, et al.
Publicado: (2021)

Capsaicin and Piperine Can Overcome Multidrug Resistance in Cancer Cells to Doxorubicin
por: Li, Hanmei, et al.
Publicado: (2018)

Reversal in multidrug resistance by magnetic nanoparticle of Fe(3)O(4) loaded with adriamycin and tetrandrine in K562/A02 leukemic cells
por: Chen, Baoan, et al.
Publicado: (2008)

Determination of the relationship between doxorubicin resistance and Wnt signaling pathway in HeLa and K562 cell lines
por: Mutlu, Pelin, et al.
Publicado: (2018)

Dual PI3K/mTOR inhibitor NVP-BEZ235 decreases the proliferation of doxorubicin-resistant K562 cells
por: Li, Jie, et al.
Publicado: (2021)

Lgr5-mediated p53 Repression through PDCD5 leads to doxorubicin resistance in Hepatocellular Carcinoma
por: Ma, Zhili, et al.
Publicado: (2019)

Usnea Acid as Multidrug Resistance (MDR) Reversing Agent against Human Chronic Myelogenous Leukemia K562/ADR Cells via an ROS Dependent Apoptosis
por: Wang, Wenjing, et al.
Publicado: (2019)

Discovery of IL-18 As a Novel Secreted Protein Contributing to Doxorubicin Resistance by Comparative Secretome Analysis of MCF-7 and MCF-7/Dox
por: Yao, Ling, et al.
Publicado: (2011)

Piperlongumine reverses doxorubicin resistance through the PI3K/Akt signaling pathway in K562/A02 human leukemia cells
por: KANG, QINGWEI, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_q37piaqpp0emd7teqb5sqelh8g